Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures a wide range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays, quality assessment, and diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. It also provides customer vial filling services. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.
Frequently asked questions
What sector does Microbix Biosystems Inc. (MBXBF) operate in?
Microbix Biosystems Inc. belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Microbix Biosystems Inc. (MBXBF) current stock price?
As of the latest data, Microbix Biosystems Inc. stock price is $0.22, with a previous close of $0.22.
What is Microbix Biosystems Inc. (MBXBF) current market capitalization?
Microbix Biosystems Inc. market cap is approximately 30.25 million.
What is Microbix Biosystems Inc. (MBXBF) Earnings Per Share (EPS)?
The trailing EPS is -$0.03.
Does Microbix Biosystems Inc. (MBXBF) pay dividends?
No. Microbix Biosystems Inc. does not pay a dividend.
When is Microbix Biosystems Inc. (MBXBF) next earnings report?
Microbix Biosystems Inc. is expected to release its next earnings report on June 30, 2026.
What is Microbix Biosystems Inc. (MBXBF) beta (volatility) score?
Microbix Biosystems Inc. has a beta of 0.573, indicating lower volatility than the overall market.
